Ruth Berthold
Muenster, NW, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
VGLL3-rearranged Spindle Cell Rhabdomyoblastic Tumor: A Clinicopathologic and Molecular Genetic Study of 18 Cases with Consistently Indolent Behavior.
Journal: Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc
Published: March 13, 2026
VGLL3-Rearranged Spindle Cell Rhabdomyoblastic Tumor: A Clinicopathologic and Molecular Genetic Study of 18 Cases With Consistently Indolent Behavior.
Journal: Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc
Published: March 13, 2026
SS18::SSX and BRD9 Modulate Synovial Sarcoma Differentiation.
Journal: Cells
Published: November 07, 2025
Exploiting WEE1 Kinase Activity as FUS::DDIT3-Dependent Therapeutic Vulnerability in Myxoid Liposarcoma.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: April 10, 2024
Interdependence of SS18-SSX-driven YAP1 and β-Catenin Activation in Synovial Sarcoma.
Journal: Molecular cancer research : MCR
Published: July 25, 2022
SS18-SSX drives CREB activation in synovial sarcoma.
Journal: Cellular oncology (Dordrecht, Netherlands)
Published: April 08, 2022
Fusion protein-driven IGF-IR/PI3K/AKT signals deregulate Hippo pathway promoting oncogenic cooperation of YAP1 and FUS-DDIT3 in myxoid liposarcoma.
Journal: Oncogenesis
Published: November 03, 2021
Recurrent CTNNB1 mutations in craniofacial osteomas.
Journal: Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc
Published: August 08, 2021
Prevalence of the Hippo Effectors YAP1/TAZ in Tumors of Soft Tissue and Bone.
Journal: Scientific reports
Published: September 12, 2019
Requirement for YAP1 signaling in myxoid liposarcoma.
Journal: EMBO molecular medicine
Published: March 23, 2019
Showing 1-10 of 10
Last Updated: 09/26/2026